Sooma tDCS is a non-invasive therapy for major depression and other disorders, developed by Finnish Sooma.
Location: Finland, Southern Finland Province, Helsinki
Employees: 11-50
Total raised: $6.85M
Founded date: 2013
Investors 3
Funding Rounds 2
| Date | Series | Amount | Investors |
| 12.03.2024 | - | $5.46M | - |
| 18.12.2019 | - | $1.39M | - |
Mentions in press and media 10
| Date | Title | Description |
| 13.03.2024 | Sooma Medical Revolutionizes Depression Treatment with €5M Funding Boost | Sooma Medical, a healthtech company based in Helsinki, Finland, has secured a €5 million funding boost to expand its innovative Transcranial Direct Current Stimulation (tDCS) at-home depression treatment. This new funding brings Sooma's tot... |
| 12.03.2024 | Finnish medtech Sooma secures €5M led by Voima Ventures | Finnish medtech Sooma secures €5M led by Voima Ventures 12 March, 2024, 15:20 Mariia Denysiuk --> --> --> -->--> --> --> --> --> --> --> --> --> Sooma, a Helsinki-based provider of brain stimulation... |
| 12.03.2024 | Helsinki-based Sooma secures €5 million to brain stimulate yourself out of depression from home | - |
| 12.03.2024 | Sooma Medical Raises €5M in Funding | Sooma Medical, a Helsinki, Finland-based provider of effective brain stimulation treatments for psychiatric and neurological disorders, raised €5M in funding. The round was led by Voima Ventures. The company intends to use the funds to acce... |
| 12.03.2024 | Finnish medtech firm Sooma bags €5M to treat neurological and psychiatric disorders: Here’s how | Read this article in: Helsinki-based Sooma, a medical device company, announced on Tuesday that it has secured €5M in growth funding led by Voima Ventures, a Nordic early-stage investor. Others, including Verge HealthTech Fund and existing ... |
| 12.03.2024 | Sooma gets €5M boost to expand its tDCS at-home depression treatment | Healthtech company Sooma Medical today announced new funding of €5 million, bringing its funding to €7.5 million. Sooma offers Transcranial Direct Current Stimulation (tDCS) through its portable neuromodulation device. tDCS uses a mild elec... |
| 18.12.2019 | SOOMA closes an investment round of over 1.2 Million EUR | Thanks to the capital increase from IAG members and Athensmed, the startup aims to take its drug-free therapy for depression to worldwide market. Sooma Oy, a Finnish medical device company developing non-invasive brain stimulation device... |
| 18.12.2019 | Sooma Medical Raises €1.25M in Funding | Sooma Medical Ltd, a Helsinki, Finland-based medical device company developing non-invasive brain stimulation devices for treatment of neurological and psychiatric disorders, raised €1.25m in funding. This included €1.0m in equity from Finn... |
| - | Sooma | “Sooma provides unique therapy solutions that combine effectiveness with ease-of-use. Therapies are based on tDCS method.” |
| - | John Collison on Stripe’s growth plans, the obsession over an IPO, and…a potential sibling cage match | Before you ask, no, I have no idea when or if Stripe is going public. And, to his credit, John Collison, Stripe president and cofounder, is even-handed about our collective obsession over it. “People love speculating on this,” he told Term ... |